［1］Rennie J, Burman-Roy S, Murphy MS. Neonatal jaundice: summary of NICE guidance［J］. BMJ, 2010, 340: c2409.

［2］Morris BH, Oh W, Tyson JE, Stevenson DK, Phelps DL, O'Shea TM, et al. Aggressive vs. conservative phototherapy for infants with extremely low birth weight［J］. N Engl J Med, 2008, 359(18): 1885-1896.

［3］Usatin D, Liljestrand P, Kuzniewicz MW, Escobar GJ, Newman TB. Effect of neonatal jaundice and phototherapy on the frequency of first-year outpatient visits［J］. Pediatrics, 2010, 125(4): 729-734.

［4］Kumar P, Murki S, Malik GK, Chawla D, Deorari AK, Karthi N, et al. Light emitting diodes versus compact fluorescent tubes for phototherapy in neonatal jaundice: a multi center randomized controlled trial［J］. Indian Pediatr, 2010, 47(2): 131-137.

［5］Mehta S, Kumar P, Narang A. A randomized controlled trial of fluid supplementation in term neonates with severe hyperbilirubinemia［J］. J Pediatr, 2005, 147(6): 781-785.

［6］Hooman N, Honarpisheh A. The effect of phototherapy on urinary calcium excretion in newborns［J］. Pediatr Nephrol, 2005, 20(9): 1363-1364.

［7］Chen A, Du L, Xu Y, Chen L, Wu Y. The effect of blue light exposure on the expression of circadian genes: bmal1 and cryptochrome 1 in peripheral blood mononuclear cells of jaundiced neonates［J］. Pediatr Res, 2005, 58(6): 1180-1184.

［8］De Luca D, Picone S, Fabiano A, Paolillo P. Images in neonatal medicine. Bronze baby syndrome: pictorial description of a rare condition［J］. Arch Dis Child Fetal Neonatal Ed, 2010, 95(5): F325.

［9］McDonagh AF. Bilirubin, copper-porphyrins, and the bronze-baby syndrome［J］. J Pediatr, 2011, 158(1): 160-164.

［10］Bertini G, Dani C, Fonda C, Zorzi C, Rubaltelli FF. Bronze baby syndrome and the risk of kernicterus［J］. Acta Paediatr, 2005, 94(7): 968-971.

［11］Matichard E, Le Henanff A, Sanders A, Leguyadec J, Crickx B, Descamps V. Effect of neonatal phototherapy on melanocytic nevus count in children［J］. Arch Dermatol, 2006, 142(12): 1599-1604.

［12］Tatli MM, Minnet C, Kocyigit A, Karadag A. Phototherapy increases DNA damage in lymphocytes of hyperbilirubinemic neonates［J］. Mutat Res, 2008, 654(1): 93-95.

［13］Karadag A, Yesilyurt A, Unal S, Keskin I, Demirin H, Uras N, et al. A chromosomal-effect study of intensive phototherapy versus conventional phototherapy in newborns with jaundice［J］. Mutat Res, 2009, 676(1-2): 17-20.

［14］Csoma Z, Hencz P, Orvos H, Kemeny L, Dobozy A, Dosa-Racz E, et al. Neonatal blue-light phototherapy could increase the risk of dysplastic nevus development［J］. Pediatrics, 2007, 119(6): 1269.

［15］Csoma Z, Hencz P, Orvos H, Kemeny L, Dobozy A, Dosa-Racz E, et al. Neonatal blue-light phototherapy could increase the risk of dysplastic nevus development［J］. Pediatrics, 2007, 119(5): 1036-1037.

［16］Csoma Z, Kemeny L, Olah J. Phototherapy for neonatal jaundice［J］. N Engl J Med, 2008, 358(23): 2523-2524.

［17］Berg P, Lindelof B. Is phototherapy in neonates a risk factor for malignant melanoma development?［J］. Arch Pediatr Adolesc Med, 1997, 151(12): 1185-1187.

［18］Brewster DH, Tucker JS, Fleming M, Morris C, Stockton DL, Lloyd DJ, et al. Risk of skin cancer after neonatal phototherapy: retrospective cohort study［J］. Arch Dis Child, 2010, 95(10): 826-831

［19］McGeady SJ. Immunocompetence and allergy［J］. Pediatrics, 2004, 113(4 Suppl): 1107-1113.

［20］Kurt A, Aygun AD, Kurt AN, Godekmerdan A, Akarsu S, Yilmaz E. Use of phototherapy for neonatal hyperbilirubinemia affects cytokine production and lymphocyte subsets［J］. Neonatology, 2009, 95(3): 262-266.

［21］Aycicek A, Kocyigit A, Erel O, Senturk H. Phototherapy causes DNA damage in peripheral mononuclear leukocytes in term infants［J］. J Pediatr (Rio J), 2008, 84(2): 141-146.

［22］Gloria-Bottini F, Bottini E. Is there a role of early neonatal events in susceptibility to allergy?［J］. Int J Biomed Sci, 2010, 6(1): 8-12.

［23］Aspberg S, Dahlquist G, Kahan T, Kallen B. Is neonatal phototherapy associated with an increased risk for hospitalized childhood bronchial asthma?［J］. Pediatr Allergy Immunol, 2007, 18(4): 313-319.

［24］Aspberg S, Dahlquist G, Kahan T, Kallen B. Confirmed association between neonatal phototherapy or neonatal icterus and risk of childhood asthma［J］. Pediatr Allergy Immunol, 2010, 21(4 Pt 2): e733-e739.

［25］Batenburg WW, Kappers MH, Eikmann MJ, Ramzan SN, de Vries R, Danser AH. Light-induced vs. bradykinin-induced relaxation of coronary arteries: do S-nitrosothiols act as endothelium-derived hyperpolarizing factors?［J］. J Hypertens, 2009, 27(8): 1631-1640.

［26］Weissman A, Berkowitz E, Smolkin T, Blazer S. Effect of phototherapy on neonatal heart rate variability and complexity［J］. Neonatology, 2009, 95(1): 41-46.

［27］Barefield ES, Dwyer MD, Cassady G. Association of patent ductus arteriosus and phototherapy in infants weighing less than 1000 grams［J］. J Perinatol, 1993, 13(5): 376-380.

［28］Benders MJ, Van Bel F, Van de Bor M. Cardiac output and ductal reopening during phototherapy in preterm infants［J］. Acta Paediatr, 1999, 88(9): 1014-1019.

［29］Grimm C, Wenzel A, Williams T, Rol P, Hafezi F, Reme C. Rhodopsin-mediated blue-light damage to the rat retina: effect of photoreversal of bleaching［J］. Invest Ophthalmol Vis Sci, 2001, 42(2): 497-505.

［30］Baba L, McGrath JM. Oxygen free radicals: effects in the newborn period［J］. Adv Neonatal Care, 2008, 8(5): 256-264.

［31］Aycicek A, Erel O. Total oxidant/antioxidant status in jaundiced newborns before and after phototherapy［J］. J Pediatr (Rio J), 2007, 83(4): 319-322.

［32］Yeo KL, Perlman M, Hao Y, Mullaney P. Outcomes of extremely premature infants related to their peak serum bilirubin concentrations and exposure to phototherapy［J］. Pediatrics, 1998, 102(6): 1426-1431.

［33］Khatami SF, Yousefi A, Bayat GF, Mamuri G. Retinopathy of prematurity among 1000-2000 gram birth weight newborn infants［J］. Iran J Pediatr, 2008, 18(2): 137-142.

［34］Ebrahim M, Ahmad RS, Mohammad M. Incidence and risk factors of retinopathy of prematurity in Babol, North of Iran［J］. Ophthalmic Epidemiol, 2010, 17(3): 166-170.

［35］Cetinkursun S, Demirbag S, Cincik M, Baykal B, Gunal A. Effects of phototherapy on newborn rat testicles［J］. Arch Androl, 2006, 52(1): 61-70.

［36］Ahlfors CE. Predicting bilirubin neurotoxicity in jaundiced newborns［J］. Curr Opin Pediatr, 2010, 22(2): 129-133.

［37］Maisels MJ, McDonagh AF. Phototherapy for neonatal jaundice［J］. New Engl J Med, 2008, 358(9): 920-928.

［38］Management of hyperbilirubinemia in the newborn infant 35 or more weeks of gestation［J］. Pediatrics, 2004, 114(1): 297-316.

［39］Stevenson DK, Wong RJ. Metalloporphyrins in the management of neonatal hyperbilirubinemia［J］. Semin Fetal Neonatal Med, 2010, 15(3): 164-168.

［40］Sharafi R, Mortazavi Z, Sharafi S, Parashkouh R. The effect of clofibrate on decreasing serum bilirubin in healthy term neonates under home phototherapy［J］. Iran J Pediatr, 2010, 20(1): 48-52.

［41］Whitelaw A, Odd D. Postnatal phenobarbital for the prevention of intraventricular hemorrhage in preterm infants［J］. Cochrane Database Syst Rev, 2007(4): CD001691.